ACM
HURA

Accent Capital Management’s TuHURA Biosciences HURA Stock Holding History

Accent Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,000
Closed -$3.58K – 357
2026
Q1 		$3.58K Sell
2,000
-1,500
-43% -$1.84K ﹤0.01% 303
2025
Q4 		$2.65K Sell
3,500
-3,500
-50% -$6.7K ﹤0.01% 335
2025
Q3 		$17.4K Hold
7,000
– – 0.01% 160
2025
Q2 		$15.6K Hold
7,000
– – 0.01% 181
2025
Q1 		$22.6K Hold
7,000
– – 0.01% 153
2024
Q4 		$28.6K Buy
+7,000
New +$37.2K 0.02% 98

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Accent Capital Management's HURA Position: Q2 2026 in Review

Accent Capital Management sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 2,000 shares — an estimated $3.58K sold.

Accent Capital Management first reported a position in HURA in Q4 2024 and held it in 6 quarters. The position peaked at $28.6K in Q4 2024. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Accent Capital Management reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Accent Capital Management sold 2,000 TuHURA Biosciences shares in Q2 2026, an estimated $3.58K.
  • Accent Capital Management first reported a position in TuHURA Biosciences in Q4 2024 and held it in 6 quarters.
  • Accent Capital Management's TuHURA Biosciences position peaked at $28.6K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.